Full Text View
Tabular View
No Study Results Posted
Related Studies
A Study to Assess the Safety and Immunogenicity of an IM Influenza Vaccine (Multimeric-001) Followed by Administration of TIV to Elderly Volunteers
This study is currently recruiting participants.
Verified August 2011 by BiondVax Pharmaceuticals ltd.
Study NCT01419925   Information provided by BiondVax Pharmaceuticals ltd.

First Received on August 17, 2011.   No Changes Posted
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Influenza
Healthy
Additional conditions recognized in this trial
Influenza, Human
More general conditions related to this trial
Orthomyxoviridae Infections
Respiratory Tract Diseases
Respiratory Tract Infections
RNA Virus Infections
Virus Diseases
Interventions listed in this trial
Multimeric-001
Multimeric-001, 500 mcg
Multimeric-001, 500mcg
Saline and TIV
Sponsors listed in this trial
BiondVax Pharmaceuticals ltd.


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services